These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 13032184)

  • 1. [Study of the residues on the terminal nitrogen atoms of bovine trypsinogen and trypsin].
    ROVERY M; FABRE C; DESNUELLE P
    Biochim Biophys Acta; 1952 Dec; 9(6):702. PubMed ID: 13032184
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study of the activation of bovine chymotrypsinogen and trypsinogen by determination of the N-terminal residues in these proteins and their corresponding enzymes].
    ROVERY N; FABRE C; DESNUELLE P
    Biochim Biophys Acta; 1953 Dec; 12(4):547-59. PubMed ID: 13140264
    [No Abstract]   [Full Text] [Related]  

  • 3. The mechanism of activation of trypsinogen. The role of the four N-terminal aspartyl residues.
    Abita JP; Delaage M; Lazdunski M
    Eur J Biochem; 1969 Apr; 8(3):314-24. PubMed ID: 5816755
    [No Abstract]   [Full Text] [Related]  

  • 4. An affinity chromatographic study of trypsinogen activation. Kinetic evidence for the existence of neotrypsinogen.
    Kasche V
    Z Klin Chem Klin Biochem; 1974 May; 12(5):242. PubMed ID: 4474754
    [No Abstract]   [Full Text] [Related]  

  • 5. STATES OF AMINO ACID RESIDUES IN PROTEINS. V. DIFFERENT REACTIVITIES WITH H2O2 OF TRYPTOPHAN RESIDUES IN LYSOZYME, PROTEINASES AND ZYMOGENS.
    HACHIMORI Y; HORINISHI H; KURIHARA K; SHIBATA K
    Biochim Biophys Acta; 1964 Nov; 93():346. PubMed ID: 14251313
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of anionic and cationic trypsinogens: the anionic activation domain is more flexible in solution and differs in its mode of BPTI binding in the crystal structure.
    Pasternak A; Ringe D; Hedstrom L
    Protein Sci; 1999 Jan; 8(1):253-8. PubMed ID: 10210204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of calcium during the activation of trypsinogen by trypsin].
    DESNUELLE P; GABELOTEAU C
    Arch Biochem Biophys; 1957 Jul; 69():475-85. PubMed ID: 13445219
    [No Abstract]   [Full Text] [Related]  

  • 8. Experimental study of interstitial injection of trypsin and trypsinogen into the pancreas.
    KEITH LM; BARNES JE; DENKEWALTER FR
    AMA Arch Surg; 1958 Sep; 77(3):416-20. PubMed ID: 13570831
    [No Abstract]   [Full Text] [Related]  

  • 9. Zymogen activation: effect of peptides sequentially related to the bovine beta-trypsin N-terminus on Kazal inhibitor and benzamidine binding to bovine trypsinogen.
    Ascenzi P; Coletta M; Amiconi G; Bolognesi M; Guarneri M; Menegatti E
    J Mol Recognit; 1988 Jun; 1(3):130-7. PubMed ID: 3273224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesotrypsin: a new inhibitor-resistant protease from a zymogen in human pancreatic tissue and fluid.
    Rinderknecht H; Renner IG; Abramson SB; Carmack C
    Gastroenterology; 1984 Apr; 86(4):681-92. PubMed ID: 6698368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The reaction of tyrosyl residues of bovine trypsin and trypsinogen with tetranitromethane.
    Kenner RA; Walsh KA; Neurath H
    Biochem Biophys Res Commun; 1968 Nov; 33(3):353-60. PubMed ID: 5749171
    [No Abstract]   [Full Text] [Related]  

  • 12. ON THE STRUCTURE AND FUNCTION OF BOVINE TRYPSINOGEN AND TRYPSIN.
    WALSH KA; KAUFFMAN DL; KUMAR KS; NEURATH H
    Proc Natl Acad Sci U S A; 1964 Feb; 51(2):301-8. PubMed ID: 14124328
    [No Abstract]   [Full Text] [Related]  

  • 13. Localization by peroxidase-labeled antibodies of bovine chymotrypsinogen.
    Schiff R; Krieg RJ; Hunter RL
    J Histochem Cytochem; 1970 Mar; 18(3):195-200. PubMed ID: 4985269
    [No Abstract]   [Full Text] [Related]  

  • 14. MECHANISM OF ZYMOGEN ACTIVATION.
    NEURATH H
    Fed Proc; 1964; 23():1-7. PubMed ID: 14114689
    [No Abstract]   [Full Text] [Related]  

  • 15. Properties of the His57-Asp102 dyad of rat trypsin D189S in the zymogen, activated enzyme, and alpha1-proteinase inhibitor complexed forms.
    Kaslik G; Westler WM; Gráf L; Markley JL
    Arch Biochem Biophys; 1999 Feb; 362(2):254-64. PubMed ID: 9989934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activating a zymogen without proteolytic processing: mutation of Lys15 and Asn194 activates trypsinogen.
    Pasternak A; Liu X; Lin TY; Hedstrom L
    Biochemistry; 1998 Nov; 37(46):16201-10. PubMed ID: 9819212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The levels of trypsinogen isoenzymes in ovarian tumour cyst fluids are associated with promatrix metalloproteinase-9 but not promatrix metalloproteinase-2 activation.
    Paju A; Sorsa T; Tervahartiala T; Koivunen E; Haglund C; Leminen A; Wahlström T; Salo T; Stenman UH
    Br J Cancer; 2001 May; 84(10):1363-71. PubMed ID: 11355948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study of the N-terminal sequences in trypsin and trypsinogen].
    DESNUELLE P; FABRE C
    Bull Soc Chim Biol (Paris); 1954; 36(1):181-8. PubMed ID: 13160748
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of the kinetic parameters of the activation of trypsinogen by trypsin.
    García-Moreno M; Havsteen BH; Varón R; Rix-Matzen H
    Biochim Biophys Acta; 1991 Oct; 1080(2):143-7. PubMed ID: 1932089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The structural properties of trypsinogen and trypsin. Alkylation and oxidation of methionines.
    Holeysovsky V; Lazdunski M
    Biochim Biophys Acta; 1968 Apr; 154(3):457-67. PubMed ID: 5689847
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.